NEW YORK, May 23 - Genomics One will market WITA Proteomics' protein analysis services in the United States and Canada, the companies said Wednesday.
WITA Proteomics, based in Teltow, Germany, offers high throughput protein analysis of cell and tissue samples using 2-D electrophoresis and mass spectrometry techniques.
Genomics One will receive a commission on sales under the terms of the deal, which is exclusive in Canada and non-exclusive in the US, said Pascal Bolon, marketing manager at WITA Proteomics.
"We don't have a lot of marketing advantage," Bolon said. "Genomics One has contacts with universities as well as companies in North America."
WITA Proteomics currently has research collaborations in Europe with Janssen Pharmaceutica, Schering, and BRAHMS Diagnostica.
WITA Proteomics employs an older method for performing 2-D gel analysis, using non-equilibrium pH gel electrophoresis (NEPHGE) technology, which is more difficult to implement but gives better results, said Bolon. WITA Proteomics claims it can resolve up to 10,000 protein spots per gel, compared to 3,000 spots for a gel collected using the more conventional immobilized pH gradient (IPG) technology.In addition to offering protein analysis services, the company can also perform toxicology studies using its 2-D gel platform and can also obtain specific tissue samples for pharmaceutical and biotechnology companies through a collaboration with Pharmagene, based in the UK, said Bolon.